Media stories about McKesson Corporation (NYSE:MCK) have been trending somewhat positive on Friday, according to Accern. The research group identifies positive and negative news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. McKesson Corporation earned a media sentiment score of 0.22 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 46.9935158566427 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
Here are some of the media headlines that may have impacted Accern Sentiment’s rankings:
- McKesson Corporation (MCK) Given Consensus Recommendation of “Hold” by Brokerages (americanbankingnews.com)
- 19.8% CAGR Healthcare IT Consulting Market: Epic Systems Corporation, Wipro Limited, Cisco Systems, IBM Corporation (medgadget.com)
- North American Computerized Physician Order Entry Market by Type, by Component – Forecast to 2019 (tmcnet.com)
- Operating Room Management Market by Solution, Delivery Mode, End User – Global Forecast to 2022 (bizjournals.com)
- McKesson Corporation (MCK) Upgraded to Outperform at Cowen and Company (americanbankingnews.com)
Shares of McKesson Corporation (NYSE MCK) opened at 150.67 on Friday. McKesson Corporation has a 52 week low of $114.53 and a 52 week high of $169.29. The company has a market capitalization of $31.68 billion, a price-to-earnings ratio of 6.84 and a beta of 1.17. The company’s 50 day moving average price is $151.86 and its 200-day moving average price is $153.56.
McKesson Corporation (NYSE:MCK) last issued its quarterly earnings data on Thursday, July 27th. The company reported $2.46 earnings per share for the quarter, missing the consensus estimate of $2.81 by ($0.35). The business had revenue of $51.05 billion during the quarter, compared to analysts’ expectations of $51.22 billion. McKesson Corporation had a return on equity of 25.76% and a net margin of 2.42%. The company’s revenue was up 2.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $3.50 earnings per share. Analysts anticipate that McKesson Corporation will post $12.07 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Monday, October 2nd. Investors of record on Friday, September 1st were given a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.90%. This is a positive change from McKesson Corporation’s previous quarterly dividend of $0.28. The ex-dividend date of this dividend was Wednesday, August 30th. McKesson Corporation’s dividend payout ratio is presently 6.07%.
Several equities analysts have weighed in on the company. Cowen and Company upgraded McKesson Corporation from a “market perform” rating to an “outperform” rating and raised their price target for the company from $176.00 to $189.00 in a report on Tuesday. Royal Bank Of Canada assumed coverage on McKesson Corporation in a report on Tuesday, September 19th. They set a “sector perform” rating and a $168.00 price target for the company. Robert W. Baird upgraded McKesson Corporation from a “neutral” rating to an “outperform” rating and raised their price target for the company from $175.00 to $178.00 in a report on Tuesday, September 19th. Morgan Stanley cut McKesson Corporation from an “overweight” rating to an “equal weight” rating and cut their price target for the company from $184.00 to $172.00 in a report on Thursday, September 14th. Finally, Needham & Company LLC upgraded McKesson Corporation from a “hold” rating to a “buy” rating and set a $179.00 price target for the company in a report on Friday, September 8th. Two research analysts have rated the stock with a sell rating, eight have given a hold rating and ten have assigned a buy rating to the company’s stock. McKesson Corporation currently has a consensus rating of “Hold” and an average price target of $172.45.
In related news, CEO John H. Hammergren sold 99,000 shares of the stock in a transaction that occurred on Friday, September 29th. The stock was sold at an average price of $153.89, for a total value of $15,235,110.00. Following the completion of the transaction, the chief executive officer now directly owns 165,000 shares in the company, valued at $25,391,850. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO John H. Hammergren sold 100,000 shares of the stock in a transaction that occurred on Friday, September 22nd. The stock was sold at an average price of $153.53, for a total value of $15,353,000.00. The disclosure for this sale can be found here. Insiders sold 952,066 shares of company stock valued at $145,736,987 over the last quarter. 1.20% of the stock is currently owned by company insiders.
McKesson Corporation Company Profile
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally.
Receive News & Ratings for McKesson Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson Corporation and related companies with MarketBeat.com's FREE daily email newsletter.